R.M. Davis Inc’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,365
| Closed | -$235K | – | 249 |
|
|
2019
Q3 | $235K | Buy |
+2,365
| New | +$225K | 0.01% | 220 |
|
|
2018
Q2 | – | Sell |
-2,501
| Closed | -$223K | – | 237 |
|
|
2018
Q1 | $223K | Sell |
2,501
-1,048
| -30% | -$101K | 0.01% | 215 |
|
|
2017
Q4 | $370K | Buy |
3,549
+480
| +16% | +$54.2K | 0.01% | 177 |
|
|
2017
Q3 | $448K | Sell |
3,069
-14
| -0.5% | -$1.91K | 0.02% | 158 |
|
|
2017
Q2 | $400K | Sell |
3,083
-477
| -13% | -$58.4K | 0.02% | 167 |
|
|
2017
Q1 | $443K | Sell |
3,560
-195
| -5% | -$23.3K | 0.02% | 156 |
|
|
2016
Q4 | $435K | Sell |
3,755
-645
| -15% | -$71.8K | 0.02% | 163 |
|
|
2016
Q3 | $460K | Sell |
4,400
-50
| -1% | -$5.41K | 0.02% | 153 |
|
|
2016
Q2 | $439K | Buy |
4,450
+1,090
| +32% | +$113K | 0.02% | 155 |
|
|
2016
Q1 | $336K | Sell |
3,360
-976
| -23% | -$100K | 0.02% | 161 |
|
|
2015
Q4 | $519K | Buy |
4,336
+16
| +0.4% | +$1.85K | 0.03% | 143 |
|
|
2015
Q3 | $467K | Buy |
4,320
+1,945
| +82% | +$241K | 0.03% | 151 |
|
|
2015
Q2 | $275K | Buy |
2,375
+153
| +7% | +$17.5K | 0.01% | 170 |
|
|
2015
Q1 | $256K | Buy |
2,222
+128
| +6% | +$15.3K | 0.01% | 171 |
|
|
2014
Q4 | $234K | Sell |
2,094
-298
| -12% | -$31.4K | 0.01% | 173 |
|
|
2014
Q3 | $227K | Sell |
2,392
-384
| -14% | -$34.7K | 0.01% | 179 |
|
|
2014
Q2 | $238K | Buy |
+2,776
| New | +$211K | 0.01% | 172 |
|
Other funds holding CELG
R.M. Davis Inc's CELG Position: Q4 2019 in Review
R.M. Davis Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,365 shares — an estimated $235K sold.
R.M. Davis Inc first reported a position in CELG in Q2 2014 and held it in 17 quarters. The position peaked at $519K in Q4 2015. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- R.M. Davis Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- R.M. Davis Inc sold 2,365 Celgene Corp shares in Q4 2019, an estimated $235K.
- R.M. Davis Inc first reported a position in Celgene Corp in Q2 2014 and held it in 17 quarters.
- R.M. Davis Inc's Celgene Corp position peaked at $519K in Q4 2015.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on R.M. Davis Inc's 13F filing for Q4 2019, filed 23 Jan 2020.